Here’s a quick overview of the article:
- We cover the background and current research around Parkinson’s disease.
- We review the latest research on CBD oil and Parkinson’s disease and explain what is currently known.
- We look at the key considerations for using CBD oil.
Parkinson’s disease is a chronic neurological condition that gets worse over time and can cause tremors, stiffness, and slower movement. There is no cure yet, but several treatments can help manage symptoms. CBD is being studied as a possible complementary option, although research is still limited.
Research on the Relationship Between CBD and Parkinson’s Disease
Research on CBD and Parkinson’s disease has grown in recent years. Most of the evidence is still preclinical, meaning it comes from lab or animal studies, so more human research is needed.
- For example, a 2014 randomized controlled trial studied varying doses of CBD in 21 people with Parkinson’s disease. The results were limited, so no firm conclusions can be drawn.
- A 2024 study involving 60 people with Parkinson’s examined CBD and cognitive measures as well as inflammation-related markers. The authors said larger studies are needed.
- A 2023 review summarized animal and lab studies on CBD and Parkinson’s disease. The authors noted that human clinical trial data are still limited, so CBD cannot yet be considered a proven option for this condition.
Currently, multiple clinical trials are underway to better understand CBD in Parkinson’s research. Many open questions remain about how it may work and how it should be studied further.
A Brief Overview of Parkinson’s Disease
Parkinson’s disease is one of the most common neurodegenerative disorders, affecting millions worldwide. It is caused by the gradual degeneration of nerve cells in a specific area of the brain called the substantia nigra. These cells produce dopamine, a chemical essential for regulating movement.
As dopamine-producing cells die off, dopamine levels in the brain decrease, disrupting the coordinated functioning of muscles. This leads to the characteristic symptoms of Parkinson’s disease: tremors, muscle stiffness, slowed movement, and in later stages, balance problems and difficulty walking.
Although the exact causes remain unclear, scientific perspectives suggest that both genetic and environmental factors may contribute to the disease. Parkinson’s typically appears after age 50, but rarer cases may occur in younger individuals. Its progression varies by person but usually worsens through several stages, significantly impacting quality of life.
How CBD Oil Works
Cannabidiol (CBD) is a non-psychoactive compound found in the cannabis plant and has become a focus of scientific interest. Some research is exploring how CBD may affect nervous system function in neurological research.
CBD is thought to interact with the body’s endocannabinoid system, which helps regulate functions like mood, sleep, pain perception, and movement. CBD does not directly activate CB1 or CB2 receptors; it appears to affect them indirectly and may influence cell signaling.
Some lab and animal studies suggest CBD may have anti-inflammatory and antioxidant activity. Research is still preliminary, and more human studies are needed to understand what that may mean in practice.
CBD Oil and Parkinson’s Disease: What the Research Says
Parkinson’s treatment often includes medications that affect dopamine levels. Researchers are also studying whether CBD may have a complementary role, but the evidence is still limited.

Early preclinical and limited clinical research is exploring whether CBD may affect sleep and anxiety-related measures in Parkinson’s disease, but the findings are not conclusive.
CBD should not replace standard Parkinson’s treatments and is not a proven therapy. It may be considered only as a complementary option within a personalized treatment plan after consulting with a doctor. Use only reliable, tested products, and consider potential drug interactions.
Symptoms and Stages of Parkinson’s Disease
The three most well-known motor symptoms of Parkinson’s disease are tremor, muscle stiffness (rigidity), and slowed movement (bradykinesia). These symptoms may be mild at first but tend to worsen over time, significantly affecting daily life.
Movement Symptoms
The most common tremor in Parkinson’s is resting tremor, occurring when the limb is at rest. Most typically, it affects the hand or fingers.
Less well-known but also frequent is “action tremor,” which happens during voluntary movements, such as reaching for an object, writing, or bringing a spoon to the mouth. This action tremor can significantly disrupt fine motor tasks and reduce quality of life.
Muscle Rigidity
Rigidity refers to constant, involuntary muscle tension which can restrict movement and cause pain. It commonly affects the arms, legs, neck, and torso. Movements become limited, joints hard to bend, and patients often report muscle fatigue or a pulling sensation. Rigidity may appear in early stages and becomes a major obstacle for daily activities like dressing and bathing as the disease progresses.
Slowed Movement (Bradykinesia)
Bradykinesia is one of the hallmark symptoms of Parkinson’s disease. Movements become slower, more awkward, and less confident. This affects not only the limbs but also:
- facial expression can become masked or frozen, often referred to as a “mask-like” face;
- shuffling gait is common, where patients do not lift their feet properly and take short, quick steps;
- initial hesitation when starting movements, or freezing episodes while moving, are also typical.
Stages of Parkinson’s Disease
The progression of Parkinson’s disease varies by individual but usually follows a slow, steady decline. The five-stage Hoehn–Yahr scale is often used to describe disease stages:
- Stage one involves mild symptoms, typically on one side of the body;
- in the middle stages, symptoms usually affect both sides, but the patient remains able to care for themselves;
- Stage five, the final stage, is marked by severe motor impairment requiring constant care and supervision.
Early Signs of Parkinson’s Disease
Early signs of Parkinson’s are often mild and mistaken for normal aging symptoms. Classic motor symptoms, like tremor or slowed movement, often appear years later.
Research suggests some early warning signs may help people get evaluated sooner.
The most common early symptoms include:
Loss of smell (hyposmia): Significant reduction or complete loss of smell often precedes motor symptoms by several years.
Sleep disturbances: Patients often experience restless sleep, vivid dreams, or sudden movements during sleep. REM sleep behavior disorder can be a strong early indicator of Parkinson’s and other neurological diseases.
Depression and anxiety: Mood disorders linked to Parkinson’s may be due to brain chemical changes affecting dopamine and serotonin pathways.
Constipation: Slowed bowel movements may suggest autonomic nervous system involvement and often precede motor symptoms.
Difficulty with fine motor skills: Changes like shaky handwriting, trouble buttoning clothes, or clumsiness with shoelaces can be early signs.
Early Parkinson’s symptoms can be easy to overlook or mistake for other health issues. If several symptoms appear together, especially in middle-aged or older adults, it’s a good idea to talk with a healthcare professional.
Parkinson’s Disease: What the Research Says So Far
The exact cause of Parkinson’s disease remains unknown, so it cannot be completely prevented. A healthy lifestyle may support overall nervous system health.
Regular exercise: Physical activity supports overall brain and body health.
Healthy diet: Foods rich in antioxidants and omega-3 fatty acids, such as leafy greens, fish, and nuts, support overall health.
Mental activity: Keeping the brain engaged through learning new skills, reading, or solving puzzles supports cognitive health.
Parkinson’s cannot be completely prevented. A healthy lifestyle may support overall nervous system health.
CBD Oil and Parkinson’s Disease: What to Know
CBD oil is still being studied as a possible complementary option for Parkinson’s disease and should only be considered after medical consultation. There are no official standardized dosing guidelines.
Dosing: A cautious approach is to start low and increase slowly only with medical guidance. The right amount can vary by person and product.
Sublingual CBD oil drops are a common option because they’re easy to use.
Points to consider:
- CBD can interact with some medications, including blood thinners and anti-epileptics. Talk with a healthcare professional before using it.
- Possible side effects include fatigue, dry mouth, appetite changes, and digestive discomfort. These are typically mild and temporary, but it is important to monitor your body’s reactions.
- Only use products from reputable sources that have been lab-tested to avoid contaminated or low-quality items.
Based on current research, CBD does not replace standard Parkinson’s medications. It may be considered a possible complementary option, but it is not a proven therapy. Talk with a healthcare professional about dosing and safety.
Premium Quality CBD Oil Products from USA Medical!
When choosing CBD products, reliable sourcing, purity, and consistent active ingredient content matter. Key features of USA Medical’s CBD oil products include:
✔ Broad-spectrum, rich in terpenes and phytocannabinoids, with no THC content.
✔ Made from organic hemp, free from heavy metals and pesticides.
✔ Made from American hemp.
✔ THC-free formula for customers who prefer CBD products without THC.
✔ Distributed by a company with reliable, responsive customer service.
✔ Has lab test results verifying purity and active ingredient content.
✔ Supported by real customer reviews and experiences.
✔ Registered EU product with a CPNP registration number.
Access our high purity, guaranteed potency, 100% THC-free CBD products here.
Details of the CBD studies and research mentioned in this article can be accessed via the embedded links in the “Sources” section in their original language.
References and Scientific Sources- Marcos Hortes N Chagas, Antonio W Zuardi, Vitor Tumas, Márcio Alexandre Pena-Pereira, Emmanuelle T Sobreira, Mateus M Bergamaschi, Antonio Carlos dos Santos, Antonio Lucio Teixeira, Jaime E C Hallak, José Alexandre S Crippa (2014): Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial.
- Witoon Mitarnun, Auempa Kanjanarangsichai, Panomporn Junlaor, Lisa Kongngern, Wenika Mitarnun, Wilasinee Pangwong,Pawarin Nonghan (2024): Cannabidiol and cognitive functions/inflammatory markers in Parkinson’s disease: A double-blind placebo-controlled trial. Int J Neurosci.
- El Ghachi Hafida, Soulimani Rachid, Gamrani Halima and Kissani Najib (2023): CBD’s potential impact on Parkinson’s disease: An updated overview. Open Medicine
- Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J. (2013): Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?
- Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. (2015): MDS clinical diagnostic criteria for Parkinson’s disease.
